Literature DB >> 24190871

Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection.

Daisuke Nagano1, Takuya Araki1, Tomonori Nakamura2, Koujirou Yamamoto1.   

Abstract

The concentration of darunavir (DRV) in peripheral blood mononuclear cells (PBMCs) was reported to affect the clinical symptoms of patients and the development of drug-resistant viruses. We developed a simple and highly sensitive method to quantify the concentration of DRV in human PBMCs using high-performance liquid chromatography with fluorescence detection. PBMC samples were collected using commercially available tubes for density-gradient centrifugation. To disrupt the cells, we used a heating fragmentation method. To compensate for the disadvantages of the heating fragmentation method, liquid-liquid partitioning was used to destroy the unbroken cells by the degeneration of proteins using an organic solvent. As an analytical column, we used an ODS column. The mobile phase consisted of 20 mmol/L potassium phosphate buffer (pH 4.3)/acetonitrile (57/43, v/v) and was pumped at 1.0 mL/min. The lower limit of quantification was 5 ng/10(6) cells. Good linearity was obtained with 5-100 ng/10(6) cells. The intra- and inter-assay precision and accuracy were <15%. Because our method makes possible the measurement of DRV concentration in PBMCs at medical facilities or laboratories without tandem mass spectrometry systems, we believe that it will contribute to clinical studies and will improve the medical treatment of human immunodeficiency virus infections with DRV.
© The Author [2013]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24190871     DOI: 10.1093/chromsci/bmt147

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  3 in total

1.  Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients.

Authors:  Daisuke Nagano; Takuya Araki; Kunio Yanagisawa; Yoshiyuki Ogawa; Fumito Gohda; Hideki Uchiumi; Hiroshi Handa; Tomonori Nakamura; Koujirou Yamamoto
Journal:  Eur J Clin Pharmacol       Date:  2018-05-02       Impact factor: 2.953

Review 2.  Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues.

Authors:  Maria A Acquavia; Luca Foti; Raffaella Pascale; Antonia Nicolò; Vincenzo Brancaleone; Tommaso R I Cataldi; Giuseppe Martelli; Laura Scrano; Giuliana Bianco
Journal:  Talanta       Date:  2020-11-05       Impact factor: 6.057

3.  Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV.

Authors:  Amedeo De Nicolò; Alice Ianniello; Micol Ferrara; Valeria Avataneo; Jessica Cusato; Miriam Antonucci; Elisa De Vivo; Catriona Waitt; Andrea Calcagno; Alice Trentalange; Giampiero Muccioli; Stefano Bonora; Giovanni Di Perri; Antonio D'Avolio
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.